biotech startups

NIH funding uncertainty spurs new biotech venture fund

Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to research institutions. Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson, co-founder and […]

NIH funding uncertainty spurs new biotech venture fund Read More »

Promise Bio exits stealth backed by Pfizer and AstraZeneca

The first thing Promise Bio CEO Ronel Veksler wants you to know about the biotech company he co-founded, is that it’s not another AI drug discovery company.  Instead, he’s looking to bring precision medicine to autoimmune diseases. Tel Aviv-based Promise Bio has developed a cloud-based AI platform that can spot different Post-Translational Modifications (PTMs) in

Promise Bio exits stealth backed by Pfizer and AstraZeneca Read More »